Synergy between CD26/DPP-IV Inhibition and G-CSF Improves Cardiac Function after Acute Myocardial Infarction

Cell Stem Cell

Volumn 4, Issue 4, 2009, Pages 313-323

  Zaruba, Marc Michael ^a   Theiss, Hans Diogenes ^a   Vallaster, Markus ^a   Mehl, Ursula ^a   Brunner, Stefan ^a   David, Robert ^a   Fischer, Rebekka ^a   Krieg, Lisa ^a   Hirsch, Eva ^a   Huber, Bruno ^a   Nathan, Petra ^a   Israel, Lars ^b   Imhof, Axel ^b   Herbach, Nadja ^b   Assmann, Gerald ^b   Wanke, Ruediger ^b   Mueller Hoecker, Josef ^b   Steinbeck, Gerhard ^a   Franz, Wolfgang Michael ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

STEMCELL

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; DIPEPTIDYL PEPTIDASE IV; DIPROTIN A; GRANULOCYTE COLONY STIMULATING FACTOR; STROMAL CELL DERIVED FACTOR 1;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL HOMING; DRUG POTENTIATION; DRUG RESPONSE; ENZYME INHIBITION; HEART FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; STEM CELL MOBILIZATION; SURVIVAL;

ANIMALS; ANTIGENS, CD26; APOPTOSIS; CHEMOKINE CXCL12; GRANULOCYTE COLONY-STIMULATING FACTOR; HEART; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; KAPLAN-MEIERS ESTIMATE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, CXCR4;

MUS;

EID: 62949195390     PISSN: 19345909     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stem.2009.02.013     Document Type: Article

References (51)

1. Abbott J.D., Huang Y., Liu D., Hickey R., Krause D.S., and Giordano F.J. Stromal cell-derived factor-1α plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110 (2004) 3300-3305
2. Aiuti A., Webb I.J., Bleul C., Springer T., and Gutierrez-Ramos J.C. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J. Exp. Med. 185 (1997) 111-120
3. Askari A.T., Unzek S., Popovic Z.B., Goldman C.K., Forudi F., Kiedrowski M., Rovner A., Ellis S.G., Thomas J.D., DiCorleto P.E., et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362 (2003) 697-703
4. Balsam L.B., Wagers A.J., Christensen J.L., Kofidis T., Weissman I.L., and Robbins R.C. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428 (2004) 668-673
5. Bleul C.C., Farzan M., Choe H., Parolin C., Clark-Lewis I., Sodroski J., and Springer T.A. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382 (1996) 829-833
6. Broxmeyer H.E., Orschell C.M., Clapp D.W., Hangoc G., Cooper S., Plett P.A., Liles C.L., Li X., Graham-Evans B., Campbell T.B., et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J. Exp. Med. 201 (2005) 1307-1318
7. Busso N., Wagtmann N., Herling C., Chobaz-Peclat V., Bischof-Delaloye A., So A., and Grouzmann E. Circulating CD26 is negatively associated with inflammation in human and experimental arthritis. Am. J. Pathol. 166 (2005) 433-442
8. Ceradini D.J., Kulkarni A.R., Callaghan M.J., Tepper O.M., Bastidas N., Kleinman M.E., Capla J.M., Galiano R.D., Levine J.P., and Gurtner G.C. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 10 (2004) 858-864
9. Christopherson K.W., Hangoc G., and Broxmeyer H.E. Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells. J. Immunol. 169 (2002) 7000-7008
10. Christopherson K.W., Hangoc G., Mantel C.R., and Broxmeyer H.E. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 305 (2004) 1000-1003
11. Christopherson K.W., Uralila S.E., Porechaa N.K., Zabriskiea R.C., Kidda S.M., and Ramin S.M. G-CSF- and GM-CSF-induced upregulation of CD26 peptidase downregulates the functional chemotactic response of CD34{thorn}CD38_ human cord blood hematopoietic cells. Exp. Hematol. 34 (2006) 1060-1068
12. Crump M.P., Gong J.H., Loetscher P., Rajarathnam K., Amara A., Arenzana-Seisdedos F., Virelizier J.L., Baggiolini M., Sykes B.D., and Clark-Lewis I. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J. 16 (1997) 6996-7007
13. Deindl E., Zaruba M.M., Brunner S., Huber B., Mehl U., Assmann G., Hoefer I.E., Mueller-Hoecker J., and Franz W.M. G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis. FASEB J. 20 (2006) 956-958
14. Dickstein K., Cohen-Solal A., Filippatos G., McMurray J.J., Ponikowski P., Poole-Wilson P.A., Stromberg A., van Veldhuisen D.J., Atar D., Hoes A.W., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur. J. Heart Fail. 10 (2008) 933-989
15. Durinx C., Lambeir A.M., Bosmans E., Falmagne J.B., Berghmans R., Haemers A., Scharpé S., and De Meester I. Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides. Eur. J. Biochem. 267 (2000) 5608-5613
16. Engelmann M.G., Theiss H.D., Hennig-Theiss C., Huber A., Wintersperger B.J., Werle-Ruedinger A.E., Schoenberg S.O., Steinbeck G., and Franz W.M. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (granulocyte colony-stimulating factor ST-segment elevation myocardial infarction) trial. J. Am. Coll. Cardiol. 48 (2006) 1712-1721
17. Fazel S., Cimini M., Chen L., Li S., Angoulvant D., Fedak P., Verma S., Weisel R.D., Keating A., and Li R.K. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J. Clin. Invest. 116 (2006) 1865-1877
18. Franz W.M., Zaruba M., Theiss H., and David R. Stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362 (2003) 675-676
19. Harada M., Qin Y., Takano H., Minamino T., Zou Y., Toko H., Ohtsuka M., Matsuura K., Sano M., Nishi J., et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat. Med. 11 (2005) 305-311
20. Hill W.D., Hess D.C., Martin-Studdard A., Carothers J.J., Zheng J., Hale D., Maeda M., Fagan S.C., Carroll J.E., and Conway S.J. SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury. J. Neuropathol. Exp. Neurol. 63 (2004) 84-96
21. Hofmann M., Wollert K.C., Meyer G.P., Menke A., Arseniev L., Hertenstein B., Ganser A., Knapp W.H., and Drexler H. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111 (2005) 2198-2202
22. Hu X., Dai S., Wu W.J., Tan W., Zhu X., Mu J., Guo Y., Bolli R., and Rokosh G. Stromal cell-derived factor-1 confers protection against myocardial ischemia/reperfusion injury role of the cardiac stromal cell-derived factor 1-CXCR4 axis. Circulation 116 (2007) 654-663
23. Huhn J., Ehrlich S., Fleischer B., and von Bonin A. Molecular analysis of CD26-mediated signal transduction in T cells. Immunol. Lett. 72 (2000) 127-132
24. Ince H., Petzsch M., Kleine H.D., Eckard H., Rehders T., Burska D., Kische S., Freund M., and Nienaber C.A. Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial. Circulation 112 (2005) I73-I80
25. Kahne T., Lendeckel U., Wrenger S., Neubert K., Ansorge S., and Reinhold D. Dipeptidyl peptidase IV: a cell surface peptidase involved in regulating T cell growth. Int. J. Mol. Med. 4 (1999) 3-15
26. Levesque J.P., Hendy J., Takamatsu Y., Simmons P.J., and Bendall L.J. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J. Clin. Invest. 111 (2003) 187-196
27. Levesque J.P., Liu F., Simmons P.J., Betsuyaku T., Senior R.M., Pham C., and Link D.C. Characterization of hematopoietic progenitor mobilization in protease-deficient mice. Blood 104 (2004) 65-72
28. Majka M., Janowska-Wieczorek A., Ratajczak J., Ehrenman K., Pietrzkowski Z., Kowalska M.A., Gewirtz A.M., Emerson S.G., and Ratajczak M.Z. Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 97 (2001) 3075-3085
29. Marguet D., Baggio L., Kobayashi T., Bernard A.M., Pierres M., Nielsen P.F., Ribel U., Watanabe T., Drucker D.J., and Wagtmann N. Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26. Proc. Natl. Acad. Sci. USA 97 (2000) 6874-6879
30. Murry C.E., Soonpaa M.H., Reinecke H., Nakajima H., Nakajima H.O., Rubart M., Pasumarthi K.B., Virag J.I., Bartelmez S.H., Poppa V., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428 (2004) 664-668
31. Naiyer A.J., Jo D.Y., Ahn J., Mohle R., Peichev M., Lam G., Silverstein R.L., Moore M.A., and Rafii S. Stromal derived factor-1-induced chemokinesis of cord blood CD34(+) cells (long-term culture-initiating cells) through endothelial cells is mediated by E-selectin. Blood 94 (1999) 4011-4019
32. Nervi B., Link D.C., and DiPersio J.F. Cytokines and hematopoietic stem cell mobilization. J. Cell. Biochem. 99 (2006) 690-705
33. Ohtsuka M., Takano H., Zou Y., Toko H., Akazawa H., Qin Y., Suzuki M., Hasegawa H., Nakaya H., and Komuro I. Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization. FASEB J. 18 (2004) 851-853
34. Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B., Pickel J., McKay R., Nadal-Ginard B., Bodine D.M., et al. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
35. Orlic D., Kajstura J., Chimenti S., Limana F., Jakoniuk I., Quaini F., Nadal-Ginard B., Bodine D.M., Leri A., and Anversa P. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. USA 98 (2001) 10344-10349
36. Ruiz P., Zacharievicha N., Vicianaa A.L., and Shenkind M. Peripheral CD34+ progenitor cells express CD26 and contain increased dipeptidyl peptidase IV activity. Acta Haematol. 100 (1998) 110-112
37. Schachinger V., Assmus B., Britten M.B., Honold J., Lehmann R., Teupe C., Abolmaali N.D., Vogl T.J., Hofmann W.K., Martin H., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J. Am. Coll. Cardiol. 44 (2004) 1690-1699
38. Scharpé S., De Meester I., Vanhoof G., Hendriks D., van Sande M., Van Camp K., and Yaron A. Assay of dipeptidyl peptidase IV in serum by fluorometry of 4-methoxy-2-naphthylamine. Clin. Chem. 11 (1988) 2299-2301
39. Segers V.F.M., Tokunou T., Higgins L.J., MacGillivray C., Gannon J., and Lee R.T. Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation 116 (2007) 1683-1692
40. Semerad C.L., Christopher M.J., Liu F., Short B., Simmons P.J., Winkler I., Levesque J.P., Chappel J., Ross F.P., and Link D.C. G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood 106 (2005) 3020-3027
41. Sexana A., Fish J.E., White M.D., Yu S., Smyth J.W.P., Shaw R.M., DiMaio J.M., and Srivastava D. Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction. Circulation 117 (2008) 2224-2231
42. Smart N., and Riley P.R. The stem cell movement. Circ. Res. 102 (2008) 1155-1168
43. Valenzuela-Fernandez A., Planchenault T., Baleux F., Staropoli I., Le-Barillec K., Leduc D., Delaunay T., Lazarini F., Virelizier J.L., Chignard M., et al. Leukocyte elastase negatively regulates stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4. J. Biol. Chem. 277 (2002) 15677-15689
44. Vanham G., Kestens L., De Meester I., Vingerhoets J., Penne G., Vanhoof G., Scharpé S., Heyligen H., Bosmans E., and Ceuppens J. Decreased expression of the memory marker CD26 on both CD4+ and CD8+ T lymphocytes of HIV infected subjects. J. Acquir. Immune Defic. Syndr. 6 (1993) 749-757
45. Vergote D., Butler G.S., Ooms M., Cox J.H., Silva C., Hollenberg M.D., Jhamandas J.H., Overall C.M., and Power C. Proteolytic processing of SDF-1 reveals a change in receptor specificity mediating HIV-associated neurodegeneration. Proc. Natl. Acad. Sci. USA 103 (2006) 19182-19187
46. Wang Y., Deng Y., and Zhou G.Q. SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model. Brain Res. 1195 (2008) 104-112
47. Wollert K.C., Meyer G.P., Lotz J., Ringes-Lichtenberg S., Lippolt P., Breidenbach C., Fichtner S., Korte T., Hornig B., Messinger D., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364 (2004) 141-148
48. Zaruba M.M., Huber B.C., Brunner S., Deindl E., David R., Fischer R., Assmann G., Herbach N., Grundmann S., Wanke R., et al. Parathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survival. Cardiovasc. Res. 77 (2008) 722-731
49. Zhou Y.Y., Wang S.Q., Zhu W.Z., Chruscinski A., Kobilka B.K., Ziman B., Wang S., Lakatta E.G., Cheng H., and Xiao R.P. Culture and adenoviral infection of adult mouse cardiac myocytes: methods for cellular genetic physiology. Am. J. Physiol. Heart Circ. Physiol. 279 (2000) 429-436
50. Zohlnhofer D., Ott I., Mehilli J., Schomig K., Michalk F., Ibrahim T., Meisetschlager G., von Wedel J., Bollwein H., Seyfarth M., et al. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. JAMA 295 (2006) 1003-1010
51. Zohlnhofer D., Dibra A., Koppara T., de Waha A., Ripa R.S., Kastrup J., Valgimigli M., Schomig A., and Kastrati A. Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis. J. Am. Coll. Cardiol. 51 (2008) 1429-1437